In addition, C0818 inhibited Hsp90 in HCC cells, leading to the proteasomal degradation of proteins in the Ras-MAPK and PI3K-AKT signaling pathways, which, as a consequence, were downregulated in C0818-treated HCC cells [56]. Here, AKT1 is linked to hepatocellular carcinoma.